Low molecular weight heparin treatment in steroid refractory ulcerative colitis: Clinical outcome and influence on mucosal capillary thrombi

Scandinavian Journal of Gastroenterology, Supplement

Volumn 36, Issue 234, 2001, Pages 41-47

  Vrij, A A ^a   Jansen, J M ^b   Schoon, E J ^b   De Bruine ^b   Hemker, H C ^b   Stockbrugger R W ^b  

^a NONE   (Netherlands)

^b NONE

Author keywords

Low molecular weight heparin; Thrombosis; Ulcerative colitis

Indexed keywords

ADJUVANT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PREDNISOLONE; ANTICOAGULANT AGENT;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTHRALGIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONFERENCE PAPER; DRUG EFFICACY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; FEMALE; HEMATOMA; HEPARINIZATION; HISTOPATHOLOGY; HUMAN; INFLAMMATORY DISEASE; MALE; MICROTHROMBUS; MYALGIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; ULCERATIVE COLITIS; ARTICLE; BLOOD; CAPILLARY; INTESTINE MUCOSA; PROSPECTIVE STUDY; THROMBOSIS; TREATMENT OUTCOME; VASCULARIZATION;

ANTICOAGULANTS; CAPILLARIES; COLITIS, ULCERATIVE; HUMAN; INTESTINAL MUCOSA; NADROPARIN; PROSPECTIVE STUDIES; THROMBOSIS; TREATMENT OUTCOME;

EID: 0034746960     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201753265091     Document Type: Conference Paper

References (20)

1. Lam A, Borda IT, Inwood MJ, Thomson S. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterolosy 1975;68:245-51.
2. Lake AM, Stauffer JQ, Stuart MJ. Hemostatic alterations in inflammatory bowel disease; response to therapy. Dis Dis 1978;23:897-902.
3. Wakefield AJ, Sawyer AM, Dhillon AP, Pittillo RM, Rowles PM, Lewis AAM, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;2:1057-62.
4. Van Wersch JWJ, Houben P, Rijken J. Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. J Clin Chem Clin Biochem 1990;28:513-7.
5. Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, et al. Granuloniatous vasculitis in Crohn's disease. Gastroenterology 1991;100:1279-87.
6. Webberly MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease; role of platelets. Gut 1993;34:247-51.
7. Souto X, Martinez E, Roca NI, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995;40:1883-9.
8. Collins CE, Rampton DS, Rogers J, Williams NS. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997;9:1213-7.
9. Vrij AA, Rijken J, van Wersch JWJ, Stockbrügger RW. Platelet factor 4 and β-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest 2000;30:188-94.
10. Graef V, Baggenstoss A, Sauer W, Spittell J. Venous thrombosis occurring in nonspecific ulcerative colitis: a necropsy study. Arch Intern Med 1966;117: 377-82.
11. Bravermar D, Bogoch A. Arterial thrombosis in ulcerative colitis. Am J Dig Dis 1978;23:1148-50.
12. Talbot R, Heppell J, Doziois R, Beart R. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-5.
13. Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992;21:127-33.
14. Hirsh J. Heparin. N Engl J Med 1991;324:1565-74.
15. Korzcnik JR. IBD: a vascular disorder? The case for heparin therapy. Inflam Bowel Dis 1997;3:87-94.
16. Zavgorodnii LG, Mustiats AP. Use of anticoagulants in the combined treatment of nonspecific ulcerative colitis. Klin Med (Mosk) 1982:60:74-80.
17. Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes DP, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995;90: 220-3.
18. Evans RC, Wong VS, Morris AI, Rhodes JM. Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases. Aliment Pharmacol Ther 1997;11:1037-40.
19. Folwaczny C, Wiebecke B, Loeschke K. Unfractionated heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 1999;94:1551-5.
20. Korzenik JR, Robert ME, Bitton A, Robinson M, Scherl EJ, et al. A multi-center, randomized, controlled trial of heparin for the treatment of ulcerative colitis. Gastroenterol 1999;166: A752.